Id2 suppression of p15 counters TGF-β-mediated growth inhibition of melanoma cells

Pigment Cell and Melanoma Research

Volumn 22, Issue 4, 2009, Pages 445-453

  Schlegel, Natalie C ^a   Eichhoff, Ossia M ^a   Hemmi, Silvio ^b   Werner, Sabine ^c   Dummer, Reinhard ^a   Hoek, Keith S ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

Cytokine susceptibility; Id2; P15

Indexed keywords

ACTIN; INHIBITOR OF DIFFERENTIATION 2; PROTEIN P15; PROTEIN P27; PROTEIN P57; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; HUMAN; HUMAN CELL; ID2 GENE; MALIGNANT TRANSFORMATION; MELANOMA CELL; METASTASIS; P15 INK4B GENE; PHENOTYPE; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MELANOMA; NEOPLASM INVASIVENESS; TRANSFORMING GROWTH FACTOR BETA;

EID: 67650115311     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00571.x     Document Type: Article

References (41)

1. Alani, R.M., Young, A.Z. Shifflett, C.B. (2001). Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. U.S.A. 98, 7812 7816.
2. Bittner, M., Meltzer, P., Chen, Y. et al. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536 540.
3. Bloethner, S., Hemminki, K., Thirumaran, R.K., Chen, B., Mueller-Berghaus, J., Ugurel, S., Schadendorf, D. Kumar, R. (2006). Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes. Melanoma Res. 16, 297 307.
4. Datto, M.B., Li, Y., Panus, J.F., Howe, D.J., Xiong, Y. Wang, X.F. (1995). Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. U.S.A. 92, 5545 5549.
5. Di, K., Ling, M.-T., Tsao, S.W., Wong, Y.C. Wang, X. (2006). Id-1 modulates senescence and TGF-beta1 sensitivity in prostate epithelial cells. Biol. Cell 98, 523 533.
6. Florenes, V.A., Bhattacharya, N., Bani, M.R., Ben-David, Y., Kerbel, R.S. Slingerland, J.M. (1996). TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Oncogene 13, 2447 2457.
7. Flores, J.F., Walker, G.J., Glendening, J.M. et al. (1996). Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res. 56, 5023 5032.
8. Geertsen, R.C., Hofbauer, G.F., Yue, F.Y., Manolio, S., Burg, G. Dummer, R. (1998). Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. J. Invest. Dermatol. 111, 497 502.
9. Gleichmann, M., Buchheim, G., El-Bizri, H., Yokota, Y., Klockgether, T., Kugler, S., Bahr, M., Weller, M. Schulz, J.B. (2002). Identification of inhibitor-of-differentiation 2 (Id2) as a modulator of neuronal apoptosis. J. Neurochem. 80, 755 762.
10. Hannon, G.J. Beach, D. (1994). p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371, 257 261.
11. Hemmi, S., Geertsen, R., Mezzacasa, A., Peter, I. Dummer, R. (1998). The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum. Gene Ther. 9, 2363 2373.
12. Heredia, A., Villena, J., Romaris, M., Molist, A. Bassols, A. (1996). The effect of TGF-beta 1 on cell proliferation and proteoglycan production in human melanoma cells depends on the degree of cell differentiation. Cancer Lett. 109, 39 47.
13. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290 302.
14. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Dobbeling, U., Kobert, N., Schaerer, L., Hemmi, S. Dummer, R. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650 656.
15. Iavarone, A., Garg, P., Lasorella, A., Hsu, J. Israel, M.A. (1994). The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8, 1270 1284.
16. Javelaud, D., Alexaki, V.I. Mauviel, A. (2008). Transforming growth factor-beta in cutaneous melanoma. Pigment Cell Melanoma Res. 21, 123 132.
17. Jennings, M.T. Pietenpol, J.A. (1998). The role of transforming growth factor beta in glioma progression. J. Neurooncol. 36, 123 140.
18. Kamesaki, H., Nishizawa, K., Michaud, G.Y., Cossman, J. Kiyono, T. (1998). TGF-[beta]1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. J. Immunol. 160, 770 777.
19. Kang, Y., Chen, C.-R. Massague, J. (2003). A self-enabling TGF[beta] response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11, 915 926.
20. Kondo, M., Cubillo, E., Tobiume, K. et al. (2004). A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ. 11, 1092 1101.
21. Kowanetz, M., Valcourt, U., Bergstrom, R., Heldin, C.H. Moustakas, A. (2004). Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol. Cell. Biol. 24, 4241 4254.
22. Krasagakis, K., Kruger-Krasagakes, S., Fimmel, S., Eberle, J., Tholke, D., Von Der Ohe, M., Mansmann, U. Orfanos, C.E. (1999). Desensitization of melanoma cells to autocrine TGF-beta isoforms. J. Cell. Physiol. 178, 179 187.
23. Lasorella, A., Iavarone, A. Israel, M.A. (1996). Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol. Cell. Biol. 16, 2570 2578.
24. Lasorella, A., Uo, T. Iavarone, A. (2001). Id proteins at the cross-road of development and cancer. Oncogene 20, 8326 8333.
25. Ling, M.T., Wang, X., Tsao, S.W. Wong, Y.C. (2002). Down-regulation of Id-1 expression is associated with TGF beta 1-induced growth arrest in prostate epithelial cells. Biochim. Biophys. Acta 1570, 145 152.
26. Lyden, D., Young, A.Z., Zagzag, D. et al. (1999). Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670 677.
27. Massague, J. Gomis, R.R. (2006). The logic of TGF[beta] signaling. FEBS Lett. 580, 2811 2820.
28. Mori, S., Nishikawa, S.I. Yokota, Y. (2000). Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. EMBO J. 19, 5772 5781.
29. Ohtani, N., Zebedee, Z., Huot, T.J.G., Stinson, J.A., Sugimoto, M., Ohashi, Y., Sharrocks, A.D., Peters, G. Hara, E. (2001). Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409, 1067 1070.
30. Onken, M.D., Ehlers, J.P., Worley, L.A., Makita, J., Yokota, Y. Harbour, J.W. (2006). Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res. 66, 4602 4609.
31. Pagliuca, A., Gallo, P., De Luca, P. Lania, L. (2000). Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res. 60, 1376 1382.
32. Perk, J., Iavarone, A. Benezra, R. (2005). Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603 614.
33. Pietenpol, J.A., Stein, R.W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R.M., Pittelkow, M.R., Munger, K., Howley, P.M. Moses, H.L. (1990). TGF-[beta]1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61, 777 785.
34. Polsky, D., Young, A.Z., Busam, K.J. Alani, R.M. (2001). The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res. 61, 6008 6011.
35. Prabhu, S., Ignatova, A., Park, S. Sun, X. (1997). Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell. Biol. 17, 5888 5896.
36. Reed, J.A., Bales, E., Xu, W., Okan, N.A., Bandyopadhyay, D. Medrano, E.E. (2001). Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res. 61, 8074 8078.
37. Rodeck, U., Bossler, A., Graeven, U., Fox, F.E., Nowell, P.C., Knabbe, C. Kari, C. (1994). Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res. 54, 575 581.
38. Rothschild, G., Zhao, X., Iavarone, A. Lasorella, A. (2006). E proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells. Mol. Cell. Biol. 26, 4351 4361.
39. Scandura, J.M., Boccuni, P., Massague, J. Nimer, S.D. (2004). Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc. Natl. Acad. Sci. U.S.A. 101, 15231 15236.
40. Straume, O. Akslen, L.A. (2005). Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. Br. J. Cancer 93, 933 938.
41. Toma, J.G., El-Bizri, H., Barnabe-Heider, F., Aloyz, R. Miller, F.D. (2000). Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis. J. Neurosci. 20, 7648 7656.